APP and Alzheimer disease: It was shown that miR-22 expression was reduced in AD patients, and complementation of miR-22 in APP/PS1 mouse model was able to significantly improve memory and behavior and inhibit the expression of pro-inflammatory cytokines such as IL-1β and IL-1 by suppressing GSDMD [86].